干预程序
About
尽管《美国发明法案》的先申请条款有效地废除了大多数新专利申请的干预程序选择权，但是对于符合提早申请日期资格的权利要求的许多专利申请，干预程序仍然是可行的。专利审判和上诉委员会的许多规则建立在先前的干预程序惯例的基础之上，一些专利审判和上诉委员会法官原属于其前身专利上诉和干预委员会。几十年来，飞翰一直为客户提供专利干预程序方面的咨询和代理，确立了国内最受推崇的干预惯例之一。我们的律师善于通过复杂的优先事项模式和《美国发明法案》过渡性条款提供导航，建议专利干预是否属于适当手段。专利干预被称为决定第一发明人的优先权争辩，从长远来看也提供了一个机会，在低于地区法院的举证标准下争论竞争者权利要求的专利性。我们的广泛业务涵盖所有技术学科和各种复杂程度，从涉及优先权的简单双方干预到涉及多方和关于优先权与可专利性等多个问题的困难案件。
经验
Represented patent owner Caavo as the junior party in two interferences related to audio-video switching devices. The PTAB granted judgment in favor of Caavo.
106,113; 106,114, PTAB, Judges Lane, Moore, Katz
Represented Biogen MA, Inc. in an interference proceeding before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO) and obtained a favorable ruling for a patent covering Tecfidera®.
106,023, PTAB, Judges Gardner-Lane, Katz, Schafer
Successfully represented PQ against Johnson Matthey in an interference related to chabazite type zeolites used for selective catalytic reduction of nitric oxides.
106,065, BPAI, Judges Schafer, Lane, Katz
Represented Sarepta and University of Western Australia in Federal Circuit appeals from interferences related to Exondys 51® (eteplirsen) for Duchenne muscular dystrophy.
16-2262, 17-1078, Fed. Cir.
Member of team that represented Sarepta and University of Western Australia in Federal Circuit appeals from interferences related to Exondys 51® (eteplirsen) for Duchenne muscular dystrophy.
16-1937, -2086, Fed. Cir.
Represented Sequenom, Inc. et al in three interference cases before the PTAB and obtained favorable rulings relating to Dr. Dennis Lo’s inventions on noninvasive prenatal diagnostics.
105,920; 105,923; 105,924, PTAB, Judges Gardner-Lane, Katz, Moore